Patient-Reported Outcomes in Acne Patients With Skin of Color Using Adapalene 0.3%-Benzoyl Peroxide 2.5%: A Prospective Real-World Study

Conclusion: Patients with SOC and moderate or severe facial acne reported high satisfaction with 0.3% A/BPO treatment and experienced good tolerability, improved QoL, treatment efficacy, and improvement in PIH. Clinicaltrials.gov number: NCT02932267 J Drugs Dermatol. 2019;18(6):514-520. PMID: 31251543 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31251543?dopt=Abstract

Source: Journal of Drugs in Dermatology - June 30, 2019 Category: Dermatology Tags: J Drugs Dermatol Source Type: research